Pain intensity VAS (0 to 100; 0 = no pain, 100 = worst pain) · adults with chronic low‐back pain
2 findings from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · adults with chronic low‐back pain
1 finding from 1 review
Pain: intermediate‐term · adults with chronic low‐back pain
1 finding from 1 review
Pain intensity, long‐term · adults with chronic low‐back pain
1 finding from 1 review
Pain intensity various scales short‐term · adults with chronic low‐back pain
2 findings from 1 review
Pain: intermediate‐term · adults with chronic low‐back pain
1 finding from 1 review
Pain intensity various scales short‐term · adults with chronic low‐back pain
1 finding from 1 review
Intervention not reported
Pain intensity various scales short‐term · adults with chronic low‐back pain
1 finding from 1 review
Intervention not reported
Pain intensity various scales intermediate‐term · adults with chronic low‐back pain
1 finding from 1 review
Intervention not reported
Other outcomes [2] (continuous outcomes) Smoking, dementia, obesity, hypertension, insomnia, anxiety, asthma, phobia)
1 finding from 1 review
Intervention not reported
Sharp reduction of 5 km/h in median speed on experimental roads after program launch. No further reduction observed despite intensified enforcement. However reduction sustained throughout the 15 month trial period.
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Intervention not reported
Pain intensity Various validated pain scales · Patients with osteoarthritis of the knee
The intervention showed no clear difference in pain intensity Various validated pain scales (low certainty).
1 finding from 1 review
Intervention not reported
Pain intensity Various validated pain scales · Patients with osteoarthritis of the knee
The intervention showed no clear difference in pain intensity Various validated pain scales (low certainty).
1 finding from 1 review
Adverse effects ‐ cardiovascular ‐ hypotension · patients with psychosis‐induced aggression or agitation
It is very uncertain whether CHLORPROMAZINE changes adverse effects ‐ cardiovascular ‐ hypotension compared with HALOPERIDOL (very low certainty).
1 finding from 1 review
Pain intensity various scales short‐term · Patients with acute low‐back pain
1 finding from 1 review
Pain intensity, long‐term · Patients with acute low‐back pain
1 finding from 1 review
Pain intensity various scales short‐term · patients with sciatica
1 finding from 1 review
Pain intensity, long‐term · patients with sciatica
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · Adult patients aged >=18 years, clinically or radiographically diagnosed with TMD (McNeill 1997 criteria); moderate to severe pain of…
Oral celecoxib (COX-2 inhibitor) showed no clear difference in pain intensity (VAS) compared with placebo; GRADE not reported.
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · Adult patients aged >=18 years, clinically or radiographically diagnosed with TMD (McNeill 1997 criteria); moderate to severe pain of…
Oral naproxen (NSAID) led to lower pain intensity (VAS) compared with placebo; GRADE not reported.
1 finding from 1 review